Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cystic Fibrosis: Management01:24

Cystic Fibrosis: Management

Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic sinusitis...
Leishmaniasis01:30

Leishmaniasis

Leishmaniasis is a protozoal disease caused by species of the genus Leishmania and transmitted through the bite of infected female sandflies. The parasite exists in two principal morphological forms during its life cycle. A sandfly acquires intracellular amastigotes from an infected reservoir host, such as a dog. Within the sandfly, these forms differentiate into motile, flagellated promastigotes. During a subsequent blood meal, promastigotes are injected into the human host, where they...
Lysosomal Hydrolases01:22

Lysosomal Hydrolases

Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
ATP Synthase: Structure01:18

ATP Synthase: Structure

ATP synthase or ATPase is among the most conserved proteins found in bacteria, mammals, and plants. This enzyme can catalyze a forward reaction in response to the electrochemical gradient, producing ATP from ADP and inorganic phosphate. ATP synthase can also work in a reverse direction by hydrolyzing ATP and generating an electrochemical gradient. Different forms of ATP synthases have evolved special features to meet the specific demands of the cell. Based on their specific feature, ATP...
Huntington Disease l: Introduction01:21

Huntington Disease l: Introduction

Huntington disease or HD is a progressive, fatal neurodegenerative disorder inherited in an autosomal dominant pattern.PathophysiologyIt is caused by expansion of the CAG trinucleotide repeat in the HTT gene on chromosome 4 (4p16.3), producing an abnormal huntingtin protein with an expanded polyglutamine tract. This misfolded protein disrupts cellular function, leading to neuronal death. Normal alleles have ≤26 repeats, 27–35 are intermediate (risk of expansion), 36–39 show reduced penetrance,...
Cushing Syndrome II: Pathophysiology01:19

Cushing Syndrome II: Pathophysiology

Cortisol production is normally governed by the hypothalamic–pituitary–adrenal (HPA) axis, which maintains hormonal balance through tightly regulated feedback mechanisms. Disruption of this regulatory system is central to the development of Cushing syndrome, whether the excess cortisol originates from external medications or internal pathology. Persistent cortisol elevation alters metabolism, immune function, and endocrine signaling, producing the characteristic clinical features of the...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

From enrichment to interpretation: PS4-driven reclassification in Taiwanese inherited retinal degeneration.

Human genomics·2026
Same author

Circadian rest-activity rhythm in patients with narcolepsy following modafinil treatment: Outcomes and predictive markers.

Sleep medicine·2026
Same author

HLA-DQB1*03:01 strongly affects age of onset of type 1 narcolepsy independently of DQA1 and ethnicity.

Proceedings of the National Academy of Sciences of the United States of America·2025
Same author

The Risks of Injury and Accident in Patients With Central Hypersomnia: A Cohort Study in Taiwan.

Journal of sleep research·2025
Same author

Population-specific polygenic risk scores for people of Han Chinese ancestry.

Nature·2025
Same author

Hidden Splicing Variants in Inherited Retinal Degeneration: Discovery and Functional Insight.

Investigative ophthalmology & visual science·2025

Related Experiment Video

Updated: Jun 13, 2026

ALS - Motor Neuron Disease: Mechanism and Development of New Therapies
15:48

ALS - Motor Neuron Disease: Mechanism and Development of New Therapies

Published on: July 29, 2007

Kleine-Levin syndrome: current status.

Yu-Shu Huang1, Clair Lakkis, Christian Guilleminault

  • 1Sleep Center, Chang Gung Memorial Hospital and University, Taoyuan, Taiwan.

The Medical Clinics of North America
|May 11, 2010
PubMed
Summary
This summary is machine-generated.

Kleine-Levin Syndrome is a rare neurological disorder causing recurring episodes of excessive sleepiness and cognitive/behavioral changes. Currently, its cause is unknown, and no treatment prevents episodes, though modafinil may shorten their duration.

Related Experiment Videos

Last Updated: Jun 13, 2026

ALS - Motor Neuron Disease: Mechanism and Development of New Therapies
15:48

ALS - Motor Neuron Disease: Mechanism and Development of New Therapies

Published on: July 29, 2007

Area of Science:

  • Neurology
  • Sleep Medicine
  • Rare Diseases

Background:

  • Kleine-Levin Syndrome (KLS) is a rare neurological disorder.
  • Characterized by recurrent episodes of hypersomnia and other symptoms.

Purpose of the Study:

  • To review current research on Kleine-Levin Syndrome.
  • Outline clinical symptoms, testing, and treatment options.

Main Methods:

  • Literature review of existing research on KLS.
  • Synthesis of clinical findings, diagnostic approaches, and therapeutic interventions.

Main Results:

  • KLS presents with periodic hypersomnia and associated symptoms.
  • The etiology of KLS remains undetermined.
  • No current treatment effectively prevents episode recurrence.

Conclusions:

  • The underlying cause of Kleine-Levin Syndrome is unknown.
  • Effective preventative treatments for KLS are lacking.
  • Modafinil may offer symptomatic relief by reducing episode duration.